Agree Realty Corp (NYSE: ADC) has a higher price-to-earnings ratio of 38.42x compared to its average ratio. ADC has 36-month beta value of 0.65. Analysts have mixed views on the stock, with 12 analysts rating it as a “buy,” 4 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for ADC is 101.68M, and currently, short sellers hold a 14.27% ratio of that float. The average trading volume of ADC on December 20, 2024 was 891.09K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ADC) stock’s latest price update
The stock price of Agree Realty Corp (NYSE: ADC) has plunged by -1.67 when compared to previous closing price of 70.62, but the company has seen a -5.70% decline in its stock price over the last five trading sessions. prnewswire.com reported 2024-12-19 that Aadi Enters into Exclusive License for Three-Asset ADC Portfolio Developed through a Collaboration between WuXi Biologics and HANGZHOU DAC Aadi Enters Agreement to Sell FYARRO® and Associated Infrastructure to KAKEN Pharmaceutical for $100M; Announces PIPE Financing of $100M Cumulative Capital Expected to Fund Operations into Late 2028, Including Anticipated Clinical Data for the ADC Portfolio Co-Founder and Former CEO of ProfoundBio, Baiteng Zhao, Appointed to Aadi Board of Directors Aadi to Hold Webcast and Conference Call on December 20 at 8:00 AM EST LOS ANGELES, Dec. 19, 2024 /PRNewswire/ — Aadi Bioscience, Inc. (NASDAQ: AADI) today announced it has entered into an exclusive license agreement for development and global commercialization of a three-asset portfolio of preclinical, next-wave antibody-drug conjugates (ADCs), in collaboration with WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), and HANGZHOU DAC BIOTECHNOLOGY CO., LTD. (HANGZHOU DAC), a global leader in ADC innovation.
ADC’s Market Performance
Agree Realty Corp (ADC) has seen a -5.70% fall in stock performance for the week, with a -10.42% decline in the past month and a -6.73% plunge in the past quarter. The volatility ratio for the week is 2.84%, and the volatility levels for the past 30 days are at 1.78% for ADC. The simple moving average for the last 20 days is -7.12% for ADC stock, with a simple moving average of 3.43% for the last 200 days.
Analysts’ Opinion of ADC
Many brokerage firms have already submitted their reports for ADC stocks, with Barclays repeating the rating for ADC by listing it as a “Underweight.” The predicted price for ADC in the upcoming period, according to Barclays is $76 based on the research report published on December 17, 2024 of the current year 2024.
Evercore ISI gave a rating of “Outperform” to ADC, setting the target price at $82 in the report published on December 12th of the current year.
ADC Trading at -7.43% from the 50-Day Moving Average
After a stumble in the market that brought ADC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.41% of loss for the given period.
Volatility was left at 1.78%, however, over the last 30 days, the volatility rate increased by 2.84%, as shares sank -9.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.82% lower at present.
During the last 5 trading sessions, ADC fell by -5.70%, which changed the moving average for the period of 200-days by +21.25% in comparison to the 20-day moving average, which settled at $74.76. In addition, Agree Realty Corp saw 10.31% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ADC starting from RAKOLTA JOHN JR, who purchase 20,000 shares at the price of $59.32 back on May 23 ’24. After this action, RAKOLTA JOHN JR now owns 436,011 shares of Agree Realty Corp, valued at $1,186,400 using the latest closing price.
Lehmkuhl Greg, the Director of Agree Realty Corp, purchase 1,000 shares at $58.99 during a trade that took place back on May 23 ’24, which means that Lehmkuhl Greg is holding 23,036 shares at $58,990 based on the most recent closing price.
Stock Fundamentals for ADC
Current profitability levels for the company are sitting at:
- 0.48 for the present operating margin
- 0.63 for the gross margin
The net margin for Agree Realty Corp stands at 0.32. The total capital return value is set at 0.04. Equity return is now at value 3.60, with 2.40 for asset returns.
Based on Agree Realty Corp (ADC), the company’s capital structure generated 0.34 points at debt to capital in total, while cash flow to debt ratio is standing at 0.16. The debt to equity ratio resting at 0.51. The interest coverage ratio of the stock is 2.91.
Currently, EBITDA for the company is 463.95 million with net debt to EBITDA at 5.33. When we switch over and look at the enterprise to sales, we see a ratio of 16.4. The receivables turnover for the company is 6.12for trailing twelve months and the total asset turnover is 0.07.
Conclusion
To put it simply, Agree Realty Corp (ADC) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
